Ecto-ATPase Activity of α-Sarcoglycan (Adhalin)*

α-Sarcoglycan is a component of the sarcoglycan complex of dystrophin-associated proteins. Mutations of any of the sarcoglycan genes cause specific forms of muscular dystrophies, collectively termed sarcoglycanopathies. Importantly, a deficiency of any specific sarcoglycan affects the expression of the others. Thus, it appears that the lack of sarcoglycans deprives the muscle cell of an essential, yet unknown function. In the present study, we provide evidence for an ecto-ATPase activity of α-sarcoglycan. α-Sarcoglycan binds ATP in a Mg2+-dependent and Ca2+-independent manner. The binding is inhibited by 3′-O-(4-benzoyl)benzoyl ATP and ADP. Sequence analysis reveals the existence of a consensus site for nucleotide binding in the extracellular domain of the protein. An antibody against this sequence inhibits the binding of ATP. A dystrophin·dystrophin-associated protein preparation demonstrates a Mg-ATPase activity that is inhibited by the antibody but not by inhibitors of endo-ATPases. In addition, we demonstrate the presence in the sarcolemmal membrane of a P2X-type purinergic receptor. These data suggest that α-sarcoglycan may modulate the activity of P2X receptors by buffering the extracellular ATP concentration. The absence of α-sarcoglycan in sarcoglycanopathies leaves elevated the concentration of extracellular ATP and the persistent activation of P2X receptors, leading to intracellular Ca2+ overload and muscle fiber death.

[1]  C. Carlson.  The Dystrophinopathies: An Alternative to the Structural Hypothesis , 1998, Neurobiology of Disease.

[2]  S. Noguchi,et al.  From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy , 1998, Muscle & nerve.

[3]  L. Kunkel,et al.  Human ϵ‐sarcoglycan is highly related to α‐sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene 1 , 1998, FEBS letters.

[4]  J. Sanes,et al.  ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D* , 1997, The Journal of Biological Chemistry.

[5]  M. Opas,et al.  Functions of dystrophin and dystrophin associated proteins. , 1997, Current opinion in neurology.

[6]  K. Campbell,et al.  Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.

[7]  H. Zimmermann,et al.  Extracellular purine metabolism , 1996 .

[8]  J. Beckmann,et al.  Advances in the molecular genetics of the limb‐girdle type of autosomal recessive progressive muscular dystrophy , 1996, Current opinion in neurology.

[9]  K. Campbell,et al.  Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. , 1996, Current opinion in cell biology.

[10]  M. Passos-Bueno,et al.  Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene , 1996, Nature Genetics.

[11]  C. Kennedy,et al.  Modulation of purinergic neurotransmission by ecto-ATPase , 1996 .

[12]  A. Filippini,et al.  Identification and characterization of an ecto-ATPase activity in rat Sertoli cells. , 1996, Biochemical and biophysical research communications.

[13]  L. Kunkel,et al.  The Three Human Syntrophin Genes Are Expressed in Diverse Tissues, Have Distinct Chromosomal Locations, and Each Bind to Dystrophin and Its Relatives (*) , 1996, The Journal of Biological Chemistry.

[14]  A. Brake,et al.  Signaling by extracellular nucleotides. , 1996, Annual review of cell and developmental biology.

[15]  L. Kunkel,et al.  Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.

[16]  K. Aldape,et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.

[17]  T. Fujiwara,et al.  Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency. , 1995, The Journal of clinical investigation.

[18]  J. Beckmann,et al.  Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity , 1995, Nature Genetics.

[19]  E. Elson,et al.  Mechanical function of dystrophin in muscle cells , 1995, The Journal of cell biology.

[20]  S. Ceoldo,et al.  Phosphorylation of dystrophin:effects on actin binding. , 1995, Biochemical and biophysical research communications.

[21]  L. Plesner.  Ecto-ATPases: identities and functions. , 1995, International review of cytology.

[22]  L. Kunkel,et al.  Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Beckmann,et al.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy , 1994, Cell.

[24]  H. Yamamoto,et al.  Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. , 1994, European journal of biochemistry.

[25]  Kensuke Hayashi,et al.  Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. , 1994, European journal of biochemistry.

[26]  G. Dubyak,et al.  Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. , 1993, The American journal of physiology.

[27]  R. Betto,et al.  Dystrophin is phosphorylated by endogenous protein kinases. , 1993, The Biochemical journal.

[28]  J. Ervasti,et al.  Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. , 1993, The Journal of biological chemistry.

[29]  F. Di Virgilio,et al.  Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. , 1993, The Journal of biological chemistry.

[30]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  N. Cusack.  P2 receptor: Subclassification and structure‐activity relationships , 1993 .

[32]  J. Towbin,et al.  Duchenne muscular dystrophy , 1993, Neurology.

[33]  P. K. Pal,et al.  The AMP-binding domain on adenylate kinase. Evidence for a conformational change during binary-to-ternary complex formation via photoaffinity labeling analyses. , 1992, The Journal of biological chemistry.

[34]  J. Ervasti,et al.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.

[35]  F. Di Virgilio,et al.  Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. , 1992, Journal of immunology.

[36]  Hideko Yamamoto,et al.  Glycoprotein‐binding site of dystrophin is confined to the cysteine‐rich domain and the first half of the carboxy‐terminal domain , 1992, FEBS letters.

[37]  M. Treuheit,et al.  Mg(2+)-ATPase from rabbit skeletal muscle transverse tubules is 67-kilodalton glycoprotein. , 1992, The Journal of biological chemistry.

[38]  K. Campbell,et al.  Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice , 1991, The Journal of cell biology.

[39]  C. Aalkjaer,et al.  Characterisation of Ca2+ or Mg(2+)-dependent nucleoside triphosphatase from rat mesenteric small arteries. , 1991, Biochimica et biophysica acta.

[40]  J. Ervasti,et al.  Purification of dystrophin from skeletal muscle. , 1991, The Journal of biological chemistry.

[41]  D. Smith,et al.  Adenosine 5'‐triphosphate increases acetylcholine channel opening frequency in rat skeletal muscle. , 1991, The Journal of physiology.

[42]  F. Di Virgilio,et al.  Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel. , 1991, The Biochemical journal.

[43]  J. Barhanin,et al.  Co-localization of the dihydropyridine receptor and the cyclic AMP-binding subunit of an intrinsic protein kinase to the junctional membrane of the transverse tubules of skeletal muscle. , 1990, The Biochemical journal.

[44]  R. Sabbadini,et al.  Biochemical properties of isolated transverse tubular membranes , 1989, Journal of bioenergetics and biomembranes.

[45]  A. Nutman,et al.  Late Archaean terrane accretion in the Godthåb region, southern West Greenland , 1988, Nature.

[46]  W. Russell,et al.  Two Ca2+-dependent ATPases in rat liver plasma membrane. The previously purified (Ca2+-Mg2+)-ATPase is not a Ca2+-pump but an ecto-ATPase. , 1988, The Journal of biological chemistry.

[47]  A. Fabiato,et al.  Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. , 1988, Methods in enzymology.

[48]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.

[49]  R. Betto,et al.  Biochemical heterogeneity of skeletal-muscle microsomal membranes. Membrane origin, membrane specificity and fibre types. , 1982, The Biochemical journal.

[50]  P. A. Lanzetta,et al.  An improved assay for nanomole amounts of inorganic phosphate. , 1979, Analytical biochemistry.

[51]  N. Birdsall,et al.  Reconstitution of a calcium pump using defined membrane components. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[52]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.